deferoxamine has been researched along with physostigmine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bowden, CA; Krenzelok, EP | 1 |
Alkon, DL; Bacia, A; Brzyska, M; Elbaum, D | 1 |
Bush, AI; Eder, P; Giordano, T; Greig, NH; Lahiri, DK; Rogers, JT; Venti, A | 1 |
2 review(s) available for deferoxamine and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical applications of commonly used contemporary antidotes. A US perspective.
Topics: Acetylcysteine; Antidotes; Antivenins; Atropine; Deferoxamine; Flumazenil; Humans; Hydroxocobalamin; Naloxone; Physostigmine; Poisoning; Succimer | 1997 |
4 other study(ies) available for deferoxamine and physostigmine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Implication of novel biochemical property of beta-amyloid.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Deferoxamine; Diethyl Pyrocarbonate; Esterases; Kinetics; Models, Molecular; Peptide Fragments; Physostigmine; Protein Conformation; Reactive Oxygen Species; Substrate Specificity | 2000 |
The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Topics: 5' Untranslated Regions; Amyloid beta-Protein Precursor; Cell Line, Tumor; Cholinesterase Inhibitors; Deferoxamine; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Neuroblastoma; Physostigmine; RNA, Messenger; Siderophores; Transfection | 2004 |